Perspectives on the chemical etiology of breast cancer

Environmental Health Perspectives

Volumn 110, Issue SUPPL. 1, 2002, Pages 119-128

  DeBruin, Lillian S ^a   Josephy, P David ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Heterocyclic amines; Mammary carcinogens; PhIP; Risk factors

Indexed keywords

ALCOHOL; AROMATIC AMINE; CARCINOGEN; DRUG METABOLIZING ENZYME; HETEROCYCLIC AMINE; HORMONE; STEROID; TOBACCO SMOKE;

ARTICLE; BREAST CANCER; BREAST MILK; CANCER RISK; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DIET; ENVIRONMENTAL FACTOR; ENZYME POLYMORPHISM; FEMALE; FOOD INTAKE; HEREDITY; HUMAN; MEAT; OCCUPATIONAL EXPOSURE; POLLUTANT; PRIORITY JOURNAL; PYROLYSIS; REPRODUCTION; RISK FACTOR; URINARY EXCRETION;

NICOTIANA TABACUM;

EID: 0036175087     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.02110s1119     Document Type: Article

References (171)

1. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland
2. Hormonal carcinogenesis
3. Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators
4. The pathway of neoplastic transformation of human breast epithelial cells
5. Basic science of HER-2/neu: A review
6. Role of HER2 gene overexpression in breast carcinoma
7. Clinical studies of Bcl-2 and treatment benefit in breast cancer patients
8. Bcl-2 gene family and related proteins in mammary gland involution and breast cancer
9. p53 tumor suppressor gene: At the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment
10. p53 mutations in breast cancer
11. The molecular epidemiology of p53 gene mutations in human breast cancer
12. A prospective trial of mid-west breast cancer patients: A p53 gene mutation is the most important predictor of adverse outcome
13. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer
14. Frequent loss of heterozygosity at the DNA mismatch-repair loci hMLH1 and hMSH3 in sporadic breast cancer
15. Hereditary breast cancer genes
16. Allelic loss at the BRCA1, BRCA2 and TP53 loci in human sporadic breast carcinoma
17. BRCA1 and BRCA2 in breast cancer
18. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells defiicint in BRCA1 or BRCA2
19. BRCA1 and BRCA2 proteins are expressed in milk fat globules
20. Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan
21. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the nurses' health study
22. Interindividual variation in CYP1A1 expression in breast tissue and the role of genetic polymorphism
23. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: Association of polymorphisms with functional differences in estrogen hydroxylation activity
24. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer
25. Genetic polymorphism of cytochrome P450 1B1 and risk of breast cancer
26. Heterologous expression of the allelic variant mu-class glutathione transferase mu and psi
27. Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk
28. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility
29. A systematic review of genetic polymorphisms and breast cancer risk
30. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk
31. Progression of human breast cancers to the metastatic state is linked to genotypes of catechol-O-methyltransferase
32. N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis
33. Bioactivation of the cooked food mutagen N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by estrogen sulfotransferase in cultured human mammary epithelial cells
34. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans
35. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk
36. Breast cancer: Magnitude of the problem and descriptive epidemiology
37. Changing incidence of breast cancer in Japanese-American women
38. Epidemiology of breast cancer in Japan
39. Breast cancer clusters in the northeast United States: A geographic analysis
40. Breast cancer risk and residence near industry or traffic in Nassau and Suffolk Counties, Long Island, New York
41. Cancers of the lung and pleura
42. Relation of breast cancer with passive and active exposure to tobacco smoke
43. Passive smoking and heart disease. Mechanisms and risk
44. Passive and active smoking and breast cancer risk in Canada, 1994-97
45. Cigarette smoking, N-acetyl-transferase 2 genetic polymorphisms, and breast cancer risk
46. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer
47. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk
48. Breast cancer and active and passive smoking: The role of the N-acetyltransferase 2 genotype
49. Alcohol and breast cancer. Where are we now and where do we go from here?
50. Alcoholic beverage consumption in relation to risk of breast cancer: Meta-analysis and review
51. Lifetime alcohol consumption and breast cancer: A case-control study in Finland
52. Alcohol and breast cancer in women: A pooled analysis of cohort studies
53. Alcohol consumption and risk of breast cancer: A cohort study
54. Alcohol consumption and breast cancer risk
55. Do insulin-like growth factors mediate the effect of alcohol on breast cancer risk?
56. A prospective study of folate intake and the risk of breast cancer
57. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women
58. Dietary fat and breast cancer
59. Meat, fat and risk of breast cancer: A case-control study from Uruguay
60. Well-done meat intake and the risk of breast cancer
61. Food heating and the formation of heterocyclic aromatic amine and polycyclic aromatic hydrocarbon mutagens/carcinogens
62. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer
63. Diet and mammary gland carcinogenesis
64. Intake of fruits and vegetables and risk of breast cancer: A pooled analysis of cohort studies
65. Dietary folate intake and breast cancer risk: Results from the Shanghai Breast Cancer Study
66. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer
67. Interaction of family history of breast cancer and dietary antioxidants with breast cancer risk (New York, United States)
68. Inclusion of women and minorities in occupational cancer epidemiologic research
69. Occupational cancer among women: Research status and methodologic considerations
70. Cancer incidence and mortality among beta-naphthylamine and benzidine dye workers in Moscow
71. Exposure to organic solvents and breast cancer in women: A hypothesis
72. Occupational risk factors for female breast cancer: A review
73. Identification of occupational cancer risks in British Columbia. A population-based case-control study of 995 incident breast cancer cases by menopausal status, controlling for confounding factors
74. Major differences in breast cancer risks among occupations
75. Occupational cancer among women: Research status and methodologic considerations
76. Occupational exposure to estrogenic chemicals and the occurrence of breast cancer: An exploratory analysis
77. The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants
78. Elevated risk for male breast cancer after occupational exposure to gasoline and vehicular combustion products
79. Breast cancer and environmental risk factors: Epidemiological and experimental findings
80. Environmental carcinogens that may be involved in human breast cancer etiology
81. The role of aromatic hydrocarbons in the genesis of breast cancer
82. Environmental and occupational pollutants are avoidable causes of breast cancer
83. Half-lives of organochlorines (OCs) in humans
84. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer
85. Blood levels of organochlorine residues and risk of breast cancer
86. High organochlorine body burden in women with estrogen receptor-positive breast cancer
87. Breast cancer and serum organochlorines: A prospective study among white, black, and Asian women
88. Risk of breast cancer and organochlorine exposure
89. Plasma organochlorine levels and the risk of breast cancer: An extended follow-up in the Nurses' Health Study
90. 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: Combined analysis of five U.S. studies
91. DDT (dicophane) and post-menopausal breast cancer in Europe: Case-control study
92. Plasma organochlorine levels and the risk of breast cancer
93. DDE and DDT in breast adipose tissue and risk of female breast cancer
94. Blood levels of DDT and breast cancer risk among women living in the north of Vietnam
95. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer
96. Serum organochlorine pesticides and PCBs and breast cancer risk: Results from a prospective analysis (USA)
97. Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations
98. Pesticides and breast cancer risk: A review of DDT, DDE, and dieldrin
99. Medical hypothesis: Xenoestrogens as preventable causes of breast cancer
100. Can environmental estrogens cause breast cancer?
101. Is there an association between exposure to environmental estrogens and breast cancer?
102. Environmental estrogens and breast cancer risk
103. Endocrine disruptors and human health - Is there a problem?
104. Organochlorine exposure and risk for breast cancer
105. An updated review of environmental estrogen and androgen mimics and antagonists
106. Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess
107. Incidence of bladder cancer in a cohort of workers exposed to 4-chloro-o-toluidine while synthesising chlordimeform
108. The Carcinogenic Potency Database: Analyses of 4000 chronic animal cancer experiments published in the general literature and by the U.S. National Cancer Institute/National Toxicology Program
109. Detection of monocyclic aromatic amines, possible mammary carcinogens, in human milk
110. Cancer risk of heterocyclic amines in cooked foods: An analysis and implications for research
111. Identification of the mutagens in cooked beef
112. Analysis of cooked muscle meats for heterocyclic aromatic amine carcinogens
113. Effects of marinating on heterocyclic amine carcinogen formation in grilled chicken
114. Heterocyclic aromatic amine formation in grilled bacon, beef and fish and in grill scrapings
115. Airborne mutagens produced by frying beef, pork and a soy-based food
116. Characterization of the carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in cooking aerosols under domestic conditions
117. Protein conformational changes determined by matrix-assisted laser desorption mass spectrometry
118. Determination of mutagenic heterocyclic amines in combustion smoke samples
119. Identification of mutagenic heterocyclic amines (IQ, Trp-P-1 and AαC) in the water of the Danube river
120. Methods for the determination of mutagenic heterocyclic amines and their applications in environmental analysis
121. Dietary carcinogens and mammary carcinogenesis. Induction of rat mammary carcinomas by administration of heterocyclic amines in cooked foods
122. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP)
123. Dose-dependent induction of mammary carcinomas in female Sprague-Dawley rats with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
124. Mammary gland carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Sprague-Dawley rats on high- and low-fat diets
125. Mammary gland carcinogenesis by 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine in rats: Possible mechanisms
126. Presence of carcinogenic heterocyclic amines in urine of healthy volunteers eating normal diet, but not of inpatients receiving parenteral alimentation
127. Exposure to heterocyclic amines
128. Cancer risk of heterocyclic amines in cooked foods: An analysis and implications for research
129. Dietary heterocyclic amines and cancer of the colon, rectum, bladder, and kidney: A population-based study
130. Heterocyclic amine levels in cooked meat and the implication for New Zealanders
131. Frequency of meat and fish intake and risk of breast cancer in a prospective study of 14,500 Norwegian women
132. Breast cancer in Argentina: Case-control study with special reference to meat eating habits
133. Consumption of meat, animal products, protein, and fat and risk of breast cancer: A prospective cohort study in New York
134. Well-done meat consumption and the risk of breast cancer
135. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high-temperature-cooked meat, and breast cancer risk
136. Breast cancer risk, meat consumption and N-acetyl-transferase (NAT2) genetic polymorphisms
137. N-Acetyl acetyl transferase 2 genotypes, meat intake and breast cancer risk
138. Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype
139. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women
140. N-Acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk
141. Mammary gland neoplasia in long-term rodent studies
142. Dietary mutagens and the risk of breast cancer
143. Detection and measurement of MelQx in human urine after ingestion of a cooked meat meal
144. Heterocyclic aromatic amines in human urine following a fried meat meal
145. Covalent binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and hemoglobin at environmentally relevant doses. Comparison of human subjects and F344 rats
146. DNA and protein adduct formation in the colon and blood of humans after exposure to a dietary-relevant dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
147. Effect of diet on serum albumin and hemoglobin adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP) in humans
148. Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP) by human cytochrome P4501B1
149. 2 atoms of guanine
150. DNA adduct formation of the food-derived mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates undergoing carcinogen bioassay
151. Carcinogen-DNA adducts in human breast tissue
152. Aromatic DNA adducts in adjacent tissues of breast cancer patients: Clues to breast cancer etiology
153. Possible mechanisms for PhlP-DNA adduct formation in the mammary gland of female Sprague-Dawley rats
154. Analysis of DNA adducts by accelerator mass spectrometry in human breast tissue after administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and benzo[a]pyrene
155. Pathways of heterocyclic amine activation in the breast: DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) formed by peroxidases and in human mammary epithelial cells and fibroblasts
156. Genotoxicity of human milk extracts and detection of DNA damage in exfoliated cells recovered from breast milk
157. Activation of genotoxins to DNA-damaging species in exfoliated breast milk cells
158. Detection of PhlP (2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine) in the milk of healthy women
159. Vegetarian diet: Panacea for modern lifestyle diseases?
160. Dose-dependent milk transfer and tissue distribution of the food mutagen PhlP in rats and their suckling pups
161. Metabolism of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by lactating Fischer 344 rats and their nursing pups
162. Increased risk of mammary carcinoma development following transplacental and trans-breast milk exposure to a food-derived carcinogen, 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhlP), in Sprague-Dawley rats
163. Distribution and metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP) in female rats and their pups at dietary doses
164. Comparative biotransformation studies of MelQx and PhlP in animal models and humans
165. Metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]-quinoxaline in human hepatocytes: 2-amino-3-methylimidazo [4,5-f]quinoxaline-8-carboxylic acid is a major detoxication pathway catalyzed by cytochrome P450 1A2
166. Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo [4,5-b]pyridine by human microsomal UDP-glucuronosyltransferases: Identification of specific UGT1A family isoforms involved
167. Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhlP) in the rat
168. Tea as a potential chemopreventive agent in PhlP carcinogenesis: Effects of green tea and black tea on PhlP-DNA adduct formation in female F-344 rats
169. Identification of urine metabolites of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine following consumption of a single cooked chicken meal in humans
170. 14C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans